About me
Emily Gebbia is the Associate Director of Regulatory Development in the Office of Scientific Investigations (OSI) in CDER’s Office Compliance at the U.S. FDA. Emily provides strategic leadership and subject matter expertise for OSI’s policy efforts, including the development of regulations and guidance related to good clinical practice, human subject protection, and postmarketing safety. She first joined FDA in CDER’s Office of Regulatory Policy as a regulatory counsel. Prior to joining FDA, Emily was an attorney at Hogan Lovells, advising a range of health sector clients, and a law clerk for the Hon. Richard C. Tallman of the Ninth Circuit Court of Appeals. Emily holds a J.D. from Catholic University of America, Columbus School of Law.
